Most acute promyelocytic leukemia (APL) cases are associated with recurrent translocations between the gene of retinoic receptor alpha and that of PML (t(15;17)) or PLZF (t(11;17)). PML localizes onto discrete intranuclear domains, the PML-nuclear bodies, and displays antioncogenic and pro-apoptotic properties. PLZF encodes a transcription factor belonging to the POZ/domain and KruÈ ppel zinc ®nger (POK) family which interacts directly with PML. PLZF is related to another POK protein, LAZ3(BCL6), which is structurally altered, and presumably misexpressed, in many non-Hodgkin lymphoma (NHL) cases. PLZF and LAZ3 share many functional properties: both inhibit cell growth, concentrate into punctated nuclear subdomains and are sequence-speci®c transcriptional repressors recruiting a histone deacetylaserepressing complex. Given these similarities, we tested whether both proteins could be targeted by each other. Here, LAZ3 and PLZF are shown to colocalize onto nuclear dots. Moreover, truncated derivatives of one protein, which display a diuse nuclear localization, are recruited onto nuclear dots by the full-length other. The colocalization and the reciprocal`rescue' is the result of a direct interaction between LAZ3 and PLZF, as indicated by yeast two hybrid assays, in vitro immunoprecipitations, and GST pull down experiments. In contrast to LAZ3 homomerization, LAZ3/PLZF heteromerization in yeast does not solely depend on POZ/POZ contacts but rather also relies on interactions between the two zinc ®nger regions and`cross' contacts between the zinc ®nger region and the POZ domain of each partner. Likewise, LAZ3 shows some colocalization with the PLZF partner PML upon stable overexpression of both proteins in CHO cells and interacts with PML in yeast. Finally, endogenous LAZ3 and PLZF are co-induced and partially colocalized in myeloid MDS cells. These data indicate that a physical interaction between LAZ3 and PLZF underlies their simultaneous recruitment onto multiproteic nuclear complexes, presumably involved in transcriptional silencing and whose integrity (for APL) and/or function (for APL and NHL) may be altered in oncogenesis. Oncogene (2000) 19, 6240 ± 6250.
Introduction
Human hematopoietic malignancies are frequently associated with speci®c karyotypic abnormalities. In some rare cases of acute promyelocytic leukemia (APL), a recurrent t(11;17) (q23;q21) translocation fuses the PLZF (for Promyelocytic Leukemia Zinc Finger) gene to that encoding the Retinoic Acid Receptor alpha (RARa). This translocation gives rise to two reciprocal hybrid proteins, RARaPLZF and PLZFRARa. PLZFRARa is suspected to play the main role in APL by acting as an antagonist of the RARs/RXRs function (Chen et al., 1994; Dong et al., 1996a) although the inocuity of the RARaPLZF fusion product is far from being proven (Yeyati et al., 1999; Sitterlin et al., 1997; Koken et al., 1999; He et al., 1999) . Based on its tissue and stage-speci®c expression, PLZF was initially postulated to play a speci®c role in early hematopoiesis (Shaknovich et al., 1998) . However, knock out analysis now indicates that it is largely implicated in development especially in patterning of the limb and axial skeleton, and Hox gene regulation (Barna et al., 2000) . In the recurrent t(15;17)(q21;q11) translocation, representing the vast majority of APL cases, the same part of RARa is fused to the PML (Promyelocytic Leukemia) gene encoding a RING ®nger nuclear matrix protein with both anti-oncogenic and pro-apoptotic properties Ferrucci et al., 1997; Quignon et al., 1998; Wang et al., 1998) and which is required for myeloid dierentiation and for some responses to retinoic acid (Wang et al., 1998) . Though unrelated in primary sequence, PML and PLZF appear to colocalize in the nucleus and to physically interact (Koken et al., 1997) . Deregulation of PLZF by either of the two APL fusion proteins, and even possibly by another APL-associated fusion protein, NPM-RARa (Hummel et al., 1999) , could provide a unifying hypothesis for explaining APL pathogenesis (Koken et al., 1997) . On the other hand, a large subset of non-Hodgkin lymphoma (NHL) cases is associated with the alteration of a gene, named LAZ3 (or BCL6) located in the 3q27 chromosomal region. LAZ3 is required for B and T cell development and/or function, though its broad expression suggests that it may also act outside the lymphoid system (Kerckaert et al., 1993; Ye et al., 1993 Ye et al., , 1997 Miki et al., 1994; Dent et al., 1997; Albagli et al., 1998) . Thus far, all known NHL-associated structural alterations of LAZ3 aect its 5' non-coding region presumably involved in the control of its expression (Ye et al., 1997 and references therein) . Accordingly, abnormal LAZ3 alleles appear to be ectopically expressed in late stages of B cell dierentiation, and thereby, may contribute to lymphomagenesis Niu et al., 1999) .
Both LAZ3 and PLZF contain a conserved and selfinteracting N-terminal domain, termed POZ (or BTB), and multiple kruÈppel-like C2-H2 zinc ®ngers at their Cterminus (ZF region), pointing out the importance of these so-called POK (POZ and kruÈppel) proteins in human cancers (Bardwell and Treisman, 1994; Dhordain et al., 1995; Davies et al., 1999 ; for a review see . In addition, recent data have emphasized the functional relationship between LAZ3 and PLZF: LAZ3 and PLZF are sequence-speci®c transcriptional repressors, which contain, in both cases, two separable repressive regions, one being the POZ domain itself, while the other one encompasses a central part between the POZ domain and the zinc ®nger region (Albagli et al., 1996; Chang et al., 1996; Seyfert et al., 1996; Baron et al., 1997; Li et al., 1997a) . Both LAZ3 and PLZF interact with the SMRT (or its relative N-CoR) and mSIN3A/B co-repressors as well as with a histone deacetylase (HDAC). Accordingly, inhibitors of HDAC activity reduce the repressive eect of both LAZ3 and PLZF on their respective cognate sequence, suggesting that they repress transcription, at least in part, by creating a repressive (hypo-acetylated) chromatin structure (Dhordain et al., 1997 Hong et al., 1997; David et al., 1998; Grignani et al., 1998; Guidez et al., 1998; Huynh and Bardwell, 1998; Lin et al., 1998; Wong and Privalsky, 1998) . For both LAZ3 and PLZF, the POZ domain as well as the central region are implicated in the recruitment of the multisubunit silencing complex, hence explaining their ability to keep some autonomous repressive activity when fused to a heterologous DNAbinding domain (Dhordain et al., 1997 David et al., 1998; Guidez et al., 1998; Huynh and Bardwell, 1998; Wong and Privalsky, 1998) . Finally, both LAZ3 and PLZF are potent growth suppressors (Shaknovich et al., 1998; Albagli et al, 1999) . In conclusion, LAZ3 and PLZF do not only display a highly related structural and functional organization, but they also share many interacting partners and, thereby, appear to repress transcription through the same overall mechanisms.
Given the striking functional convergences between these two oncogenic POK proteins, we examined whether they could be targeted by each other. Here, it is shown that LAZ3 and PLZF are colocalized onto nuclear dots and the proteins are capable of reciprocal rescue' as truncated derivatives of one protein, displaying a diuse nuclear localization, can be recruited onto nuclear dots by the other full-length one. This strongly suggests that both proteins interact directly, a conclusion further corroborated by two hybrid studies in yeast and in vitro interaction assays. Our data suggest that a physical interaction between LAZ3 and PLZF underlies their simultaneous recruitment in multiproteic nuclear complexes presumably involved in transcriptional silencing.
Results

Colocalization between LAZ3 and PLZF
In various cell lines transiently or stably transfected with LAZ3 encoding vectors, immuno¯uorescence (Dhordain et al., , 1997 Seyfert et al., 1996; Huynh and Bardwell, 1998; Okabe et al., 1998; Davies et al., 1999; Albagli et al., 1999) and electron-microscopy analysis (Albagli et al. (submitted) ) showed either large empty spherical or smaller punctate nuclear substructures. This pattern is remarkably similar to the PLZF immuno¯uores-cence images which we described previously (Koken et al., 1997) . To assess the colocalization between the two proteins, COS6 or CHO cells were transiently or stably (not shown) transfected with both LAZ3 and PLZF expression vectors. These experiments reveal a complete colocalization onto large intranuclear structures ( Figure 1a) . Indistinguishable results were obtained when PLZF was transiently transfected in UTA-L cells (Albagli et al., 1999) which stably harbour a tetracycline-regulated LAZ3 gene (data not shown). Moreover, when co-expressed with LAZ3, the PLZFRARa chimera no longer seems to exhibit its`normal' micropunctated but rather colocalizes with LAZ3 onto large intranuclear dots ( Figure 1b) . Thus, LAZ3 colocalizes with both PLZF as well as with its oncogenic hybrid derivative, PLZFRARa.
Transfection with several PLZF and LAZ3 mutants shed light on the diferent domains important for this colocalization ( Figure 2 and Table 1 ). Colocalization still occurs when either LAZ3 or PLZF is missing its POZ domain. In both these cases, the punctated full length protein (either LAZ3 or PLZF) is able to recruit its otherwise`diuse' partner (PLZFDPOZ or LAZ3DPOZ, respectively) onto nuclear dots ( Figure 2a and Table 1 ). Thus despite the role of the POZ domain in mediating the homodimerization of both LAZ3 and PLZF Li et al., 1997c Li et al., , 1999 , the colocalization between the two proteins does not need absolutely a contact between their POZ domains.
In the same way, the integrity of the ZF (zinc ®nger) region in one partner is not required for colocalization as the (otherwise diuse) LAZ3DZF (Figure 2b and Table 1 ) and the PLZFRARa (Figure 1b ) (lacking the last seven zinc ®ngers of PLZF) are recruited onto PLZF and LAZ3 bodies, respectively. Note, that this also indicates that not only the POZ domain (Dhordain et al., 1995, this study) but also the ZF region contributes to the formation of the LAZ3 nuclear bodies. However, though dispensable for the colocalization, the isolated ZF region of LAZ3 on its own can yet be recruited onto PLZF dots (Table 1) . A simple explanation for these data is that LAZ3 and PLZF colocalize thanks to redundant (direct or indirect) contacts mediated by two interaction faces: the N-terminal POZ domain and the C-terminal zinc ®nger region. The absence of colocalization between wildtype LAZ3 and the diusely localized PLZFRARa mutant lacking both the POZ domain as well as the nine zinc ®ngers ( Figure 2c and Table 1 ) further corroborates this view.
In summary, a full length PLZF is able to (directly or indirectly) confer a punctate nuclear localization to the otherwise more diuse truncated derivatives of LAZ3. Conversely, LAZ3 recruits onto nuclear dots the more diuse PLZFDPOZ derivative. This reciprocal`rescue' suggests that LAZ3 and PLZF can interact with each other.
LAZ3 and PLZF interact in vivo
The possibility for an interaction between LAZ3 and PLZF was next examined using the yeast two hybrid system. As shown in Table 2 , coexpression of both LAZ3 and PLZF strongly activates the b-galactosidase encoding reporter, demonstrating an interaction between LAZ3 and PLZF in vivo. In an attempt to dissect the domains responsible for this interaction, several LAZ3 and PLZF derivatives were tested in this assay (Table 2) .
Given its prominent role in mediating POK protein self-interaction especially in the case of LAZ3 and PLZF (Bardwell and Treisman, 1994; Dhordain et al., 1995; Li et al., 1997c Li et al., , 1999 , or interaction between distinct POK proteins (Okabe et al., 1998), we ®rst tested whether the heteromerization between LAZ3 and PLZF relies on a POZ/POZ contact. We thus evidenced that the two isolated POZ domains readily interact with each other, as well as with the isolated ZF region of the partner in a reciprocal fashion (POZ(LAZ)/ZF(PLZF and POZ(PLZF)/ZF(LAZ). However, our results also suggest that the interaction between LAZ3 and PLZF not only relies on their POZ domain. In the same system, we also show that: (i) in agreement with the results obtained in the colocalization experiments ( Figure 2 and Table 1), the deletion of the POZ domain of LAZ3 does not aect its ability to associate with PLZF. Thus, LAZ3/PLZF heteromerization does not strictly require a POZ/POZ interaction: (ii) the isolated POZ domain of PLZF only weakly interacts with LAZ3 (POZ(PLZF)/LAZ), while even no interaction can be found in the reciprocal experiments (POZ(LAZ)/PLZF) suggesting that the POZ domains do not provide a strong heteromerization interface with the full length partner-protein.
In contrast, the isolated ZF region of LAZ3 eciently interacts with PLZF (possibly supporting their colocalization in animal cells and vice versa (ZF(LAZ)/PLZF and ZF(PLZF)/LAZ). Additionally, the two isolated ZF regions bind well to each other. Finally, the deletion of the ZF region of PLZF`w eakens' the interaction with LAZ3, which is totally abrogated by the deletion of the zinc ®ngers in both proteins. This last result also argues against an implication of the region localized between the POZ and ZF domains in the LAZ-PLZF contacts, in agreement with the colocalization studies (Figure 2c ). These results also point to a role of the two ZF regions in mediating LAZ3/PLZF heteromerization. Note, however, that a LAZ3 derivative lacking the ZF region is still able to bind PLZF, indicating, together with the colocalization experiments (Figure 2 and Table 1 ), an Colocalization between the wildtype PLZF and truncated LAZ3 derivatives. COS6 cells were transfected with expression vectors and immuno¯uorescence analysis was performed. LAZ3DPOZ (a) and LAZ3DZF (b) derivatives are shown in red, and PLZF in green. Note that the singly transfected LAZ3DPOZ (a) and LAZ3DZF (b) proteins (in red) display a nuclear diuse pattern. In (c), the co-transfection of the double-deleted PLZFDPOZDZF mutant and wildtype LAZ3 is shown. Note the completeabsence of colocalization, corroborating the importance of the POZ and ZF region for the heteromerization apparent redundancy between the contacts mediated by the N-terminal part of LAZ3 (including the POZ domain) and its ZF region.
In summary (lower panel of Table 2 ), we conclude that: (1) multiple contacts are involved in the LAZ3/ PLZF heteromerization: (2) both the two POZ domains and the two ZF regions are able to engagè homo' association (POZ(LAZ)/POZ(PLZF) and ZF(LAZ)/ZF(PLZF) as well as reciprocal`cross' association (ZF(LAZ)/POZ(PLZF) and ZF(PLZF)/ POZ(LAZ)): (3) the LAZ3/PLZF interaction does not strictly require POZ/POZ contacts nor ZF/ZF contacts: (4) despite the redundancy between the Nterminal-and ZF-mediated contacts, we found the isolated ZF regions of both LAZ3 and PLZF but not the isolated POZ domains provide an ecient interaction surface to the full length partner. Thus, in contrast to LAZ3/LAZ3 or PLZF/PLZF homomerization, for which the POZ domain plays a predominant, if not exclusive role Li et al., 1997c) , it appears that the ZF regions play an at least as important role for LAZ3/PLZF heteromerization.
Colocalization between LAZ3 and PML upon stable overexpression of both proteins
Although some cases express the PLZFRARa fusion proten, APL is most typically associated with the expression of the PMLRARa hybrid protein. We previously showed that PLZF and PML can both colocalize onto nuclear bodies and directly interact (Koken et al., 1997) . Here it is shown that LAZ3 associates with PLZF and therefore this last protein should normally also colocalize with PML on the PML nuclear bodies. This appears to contradict our previous experiments in which transiently expressed LAZ3 did not colocalize with endogenous PML . However stable cotransfection of LAZ and PML in CHO cells (Figure 3a) , results in some colocalization of LAZ3 and PML in a few cells about 2 weeks post transfection. Likewise, both proteins are able to interact in the yeast two hybrid assay (Figure 3b ). Why the establishment of the colocalization between LAZ3 and PML occurs`lately' whereas the LAZ3/ PLZF colocalization is quickly observable remains unclear (see Discussion). Noteworthy, we reported a similar observation for the PLZF/PML colocalization which was more easily detected in stable than in transient transfections (Koken et al., 1997) .
LAZ3 and PLZF interact directly
Although the above-mentioned experiments indicate that PLZF and LAZ3 can associate in vivo, they cannot clarify whether the interaction is direct or indirect. Therefore, both proteins were in vitro translated, mixed together and immunoprecipitated with either an anti-LAZ3 or an anti-PLZF antibody. Subsequently the precipitates were subjected to Western blot analysis with either anti-PLZF or anti-LAZ3 antibodies, respectively (Figure 4 , upper panels). In this way we observed retention of PLZF onto immunoprecipitated LAZ3 and vice versa. Moreover, PLZF and LAZ3 were in vitro translated in the presence of Immuno¯uorescence was performed about 2 weeks after transfections. Note that co-expression of PML and LAZ3 appears to be very toxic to the cells which quickly die or shut down one or both of the genes, resulting in only very rare cells co-expressing both proteins. (b) Two-hybrid study results in yeast. Yeast was transfected with pGBT9-LAZ3 (wildtype) together with pACTII-PML and bgal-activity was determined as described in Materials and methods. The bgal-activity resulting in the transfection of pGBT9-LAZ3 (wildtype) together with the empty pACTII is again taken as 1. Six independent experiments were performed and the mean is plotted tions, both LAZ3 and (as expected) PLZF interact with the GST-PLZF protein (Figure 4 , lower panel). Taken together, these results strongly suggest that the interaction between both proteins is direct.
Physiological relevance of the PLZF and LAZ3 colocalization/association
As the above results are based on arti®cial systems, cell lines were tested for co-expression of endogenous PLZF and LAZ3 in the same cells. PLZF expression was primarily detected in early hematopoietic progenitors while LAZ3 appears to be broadly expressed at various levels. Northern and Western blot analysis was performed on dierent cell lines. Upon treatment with the calcium ionophore A23187, the MDS cells, which exhibit some myeloid characteristics, acquire a monocytoid phenotype (Licht et al., 1996) and upregulate both PLZF and LAZ3 mRNA (Figure 5a ; Licht et al., 1996) . In these cells, LAZ3 and PLZF were found to be coexpressed in some cells and to partiallỳ colocalize' onto very small punctated nuclear bodies (Figure 5b,c) . Thus, at least in myeloid cells, endogenous LAZ3 and PLZF show coexpression and partial colocalization. In addition, these data provide clear evidence for a micropunctated nuclear localization of the endogenous LAZ3 protein (Cattoretti et al., 1995) . Note, however, that some calcium-ionophore induced MDS cells express high level of LAZ3 and very low, if any, level of PLZF, and vice versa, suggesting that the two genes may undergo distinct regulation during the cell-cycle and/or dierentiation of myeloid cells. Interestingly, in some MDS cells, the PLZF staining appears to separate two distinct compartments in the cell nucleus (Figure 5c ).
Discussion
POZ/Zinc ®nger (POK) proteins commonly aggregate in large nuclear complexes by self-interaction and association with unrelated partners, such as transcriptional corepressors (Davies et al., 1999) . In addition, there is increasing evidence that some POK proteins can also form heterodimers with other distinct POK proteins. For instance, in Drosophila, the two POK developmental regulators GAGA and TTK bind to each other, at least in vitro (Bardwell and Treisman, 1994) , while in vertebrates, the LAZ3 protein interacts with two distinct POK proteins, its close relative BAZF, and the more distantly related LRF (FBI-1) (Davies et al., 1999; Okabe et al., 1998) . It has been proposed that the interaction between POK proteins might extend the repertoire of their target genes and/or the ways they act on their expression (Davies et al., 1999) .
In this study, we focused on the two proteins involved in human hematopoietic malignancies, LAZ3, frequently altered in non-Hodgkin lymphomas, and PLZF, which is fused to RARa in some cases of acute promyelocytic leukemia. Previous studies indicated that both proteins accumulate in nuclear dots and act as sequence-speci®c transcriptional repressors whose function relies on the recruitment of a SIN3/ SMRT (or NCoR)/HDAC complex. Here we show that forced co-expression of LAZ3 and PLZF leads to their complete colocalization onto nuclear dots. Consistently, a colocalization, albeit partial, is also observed between endogenous LAZ3 and PLZF in myeloid cells, indicating that a fraction of LAZ3 and PLZF is engaged in a common nuclear environment when expressed at physiological levels. Moreover, in vitro immunoprecipitations and GST pull down assays indicate that a direct physical contact underlies the observed colocalizations. Though the isolated POZ domains of LAZ3 and PLZF are able to associate with each other in the yeast two hybrid system, a LAZ3 derivative lacking the POZ domain (LAZ3DPOZ) readily colocalizes and interacts with PLZF. Thus, despite the essential role of POZ/ POZ association for LAZ3 homomerization and localization on nuclear dots , the heteromerizatin between LAZ3 and PLZF does not solely rely on POZ/POZ contacts. Interestingly, the isolated ZF region of PLZF interacts with LAZ3 while, conversely, the homologous region of LAZ3 both associates (in yeast) and colocalizes (in vertebrate cells) with PLZF. These ®ndings suggest that the ZF regions also play an important role for LAZ3 and PLZF to interact. We further dissected this role by showing that the ZF regions both bind to each other and interact with the POZ domain of the partner. Thus, each ZF region mediates both`homo'merization (ZF/ZF interaction) and reciprocal`cross' contacts (ZF/POZ interaction). Many other families of transcription factors, have exempli®ed a role for the zinc ®ngers in protein/protein interaction (reviewed by Mackley and Crossley, 1998) . In the case of the POK proteins the ZF region was reported to be necessary for ZF5 self binding (Numoto et al., 1999) or for LAZ3/LRF (FBI-1) interaction (Davies et al., 1999; Morrison et al., 1999) . We show here, that each zinc ®nger region can even be sucient for distinct POK proteins to associate. Perhaps the ZF regions provide an important heteromerization interface when the POZ domains are too distant to ensure stable association between distinct but interacting POK proteins, much as recently proposed for the LAZ3/LRF (FBI-1) interaction (Davies et al., 1999) . Note, however, that, like the LAZ3DPOZ mutant, the LAZ3DZF derivative also colocalizes with PLZF in vertebrate cell nuclei and keeps the ability to interact with PLZF in yeast. (Figure 3) . Moreover, the POZ domain of PLZF at its own interacts, albeit weakly, with LAZ3. Thus, several regions, including the POZ domain and ZF regions of both LAZ3 and PLZF appear to contribute to the interaction.
Although the partial colocalization of endogenous LAZ3 and PLZF in myeloid cells indicates the physiological relevance of our ®ndings, we were unable to detect a clear cooperation for the repression via a LAZ3 target through transient transfection assays (data not shown), and thus, the functional consequences of the LAZ3/PLZF interaction remain to be de®ned. Given the interaction of both LAZ3 and PLZF with the SIN3/SMRT (NCoR)/HDAC complex, it is yet conceivable that at least part of these LAZ3/ PLZF containing nuclear dots represent transcriptional silencing`factories' in which both LAZ3 and PLZF target genes are shut o through the formation of repressing chromatin structures. Accordingly, the interaction/colocalization between LAZ3 and PLZF might facilitate the recruitment of the histone deacetylase repressing complex and/or the steering of genes fated to be silenced into repression territories within the nucleus. Such a`dragging' eect has been suggested (7) with the Ca-ionophore A23187 during 48 h. PolyA + RNA was isolated and 5 mg were analysed. A clear induction of both LAZ3 and PLZF mRNAs is observed. Note that in addition to the previously described high molecular weight PLZF mRNA, these cells also express a shorter 2.6 kb transcript. (b) Confocal microscopy analysis of endogenous PLZF (red) and LAZ3 (green) expression in Ca-ionophore-induced MDS cells. Although colocalization is partial, several small dots or regions (arrowheads) are clearly labelled by both antibodies. The lower left panel shows a vertical section taken through the Z-serie of the same image (between the two arrows in the two colour pictures (upper right panel)) indicating that PLZF and LAZ3 at this position in the cell are present throughout all Z-serie sections. (c) Three representative CCD-camera image analysis of Caionophore-induced MDS cells labelled with anti-LAZ3 (green) and anti-PLZF (red) antibodies. In the middle panel a cell displays a clear colocalization in small dots (arrow). Although colocalization is very partial, some clearly colocalizing dots are visible (arrowheads). Apparently, LAZ3 and PLZF are dierentially regulated during the cell cycle or dierentiation, as shown by the very heterogenous ratio between the two expression levels in the dierent cells. Note, that the PLZF monoclonal antibody staining seems to delimit a nuclear subdomain of unknown function in many of the cells for the IKAROS transcription factor, which also forms nuclear dots and recruits a histone-deacetylase containing complex, and is now believed to repress transcription by mediating local histone deacetylation and nuclear reorganization bringing its target genes into the close proximity of centromeric heterochromatin (Brown et al., 1997; Koipally et al., 1999) . Interestingly, it has been reported recently that another POK protein, RP58, both represses transcription and localizes almost exclusively within highly condensed chromatin regions (Aoki et al., 1998) . Thus, LAZ3/ PLZF nuclear dots might also represent, at least in part, nuclear sites devoted to transcriptional repression through chromatin remodeling. Conceivably the alteration of the function of such LAZ3/PLZF-containing nuclear complexes upon either LAZ3 or PLZF alteration might play a role in the pathogenesis of both BHL and APL. What could it mean, in this context the colocalization between both PLZF and LAZ3, with PML? A ®rst possibility would be that both LAZ3 and PLZF might exert their transcriptional eect in PML nuclear bodies as they are also suspected to act in transcriptional control and chromatin modelling (Seelers et al., 1998; Doucas et al., 1999) . However, the colocalization between LAZ3 and PLZF is dierent from that of PML with both PLZF and LAZ3 in that the ®rst one can be observed very quickly, while the second one only appears later. Moreover, the LAZ3 bodies appear to be associated with nascent DNA (Albagli et al., 1999, Albagli et al., in press) whereas no DNA was ever detected inside the PML nuclear bodies. It has been recently shown that various RING ®nger proteins may target their associated protens to degradation through the ubiquitin/proteasome pathway (Lorick et al., 1999) . In this regard, it is worth noting that in the precursors of Drosophila photoreceptors, the RING ®nger protein SINA interacts with the POK protein TTK and is required for its proteasome-mediated degradation (Li et al., 1997b; Tang et al., 1997) . Thus, we should consider the possibility that PLZF and LAZ3 ®rst concentrate (and colocalize) in nuclear sites of transcriptional control while (possibly because of their overexpression) they are then shuttled to nuclear bodies through interaction with PML to be stored, exported or degraded.
Materials and methods
Cell culture and transfection
COS6 and CHO cells were grown and transfected in DMEM 10% FCS. UTA-L cells were grown in DMEM 10% FCS, 2 mg/ml tetracycline, 1 mg/ml puromycine and 500 mg/ml G418 (Albagli et al., 1999) and induced to express LAZ3 by extensive washing to remove tetracyclin. The human myelodysplastic cell line, MDS (Banerjee et al., 1992) was grown and induced with Ca-ionophore A23187 according to Licht et al. (1996) . Cells were transfected using Lipofectin (Life Technologies) or Fugene 6 (Roche) according to the manufacturer's instructions.
Plasmids
Mammalian expression vectors LAZ3 and all its deleted derivatives were inserted into the SV40-based expression vector pTL-1. The LAZ3DPOZ derivative corresponds to amino-acids (132 ± 706) , the LAZ3DZF corresponds to amino-acids (1 ± 500) and the ZF derivative corresponds to amino-acids (515 ± 706) (Albagli et al., 1996 (Albagli et al., , 1999 . The expression vectors encoding PLZF, PLZF-RARa and PLZFDPOZ have been previously described (Chen et al., 1994; Dong et al., 1996b) . The PML vector pSG5-PML was previously described (De TheÂ et al., 1991) .
Yeast expression vectors The PGBT9 (Clontech) derivative containing partial or full length LAZ3 sequences fused to the GAL4 DNA binding domain were previously described (Dhordain et al., , 1997 . The POZ(LAZ3) domain insert corresponds to amino acids (1 ± 40), LAZ3DPOZ to amino acids (132 ± 706), ZF(LAZ3) to amino-acids (515 ± 706) and funally LAZ3DZF to amino acids (1 ± 500) (Dhordain et al., 1996; Albagli et al., 1996 Albagli et al., , 1999 . The PML containing pACTII (Clontech) vector was previously described (Koken et al., 1997) , and references therein) pACTII-PLZF harbours an NdeI ± XhoI fragment of the PLZF cDNA; pACTII-POZ(PLZF) was constructed by ligating the 5' NcoI ± EagI fragment of the PLZF cDNA into NcoI ± BamHI sites of pACTII, by ligation of an EagI/ BamHI adapter; pACTII-ZF(PLZF) was constructed by ligating the 3' NcoI ± BamHI fragment into the NcoI ± BamHI sites of pACTII.
Two hybrids assays
Yeast strain used was PJ69-4A (James et al., 1996) . Media were prepared as described by Rose et al. (1990) . All yeast transformations were performed using the high eciency Table 2 Physical interaction in vivo between LAZ3 and PLZF Upper panel: Two-Hybrid assays in yeast are shown. Vertically, LAZ3 and deletion mutants cloned into the pGBT9 vector (Gal4-DBD) are shown. Horizontally, PLZF and its derivatives, cloned into the pACTII (Gal4-AD) are indicated. 1, indicates the b-gal value obtained after transfection of the empty pACT2 vector with each of the LAZ3 pGBT9-constructs. This value was arbitrarily taken as 1. To give an example, the interaction between wildtype pGBT9-LAZ3 and wildtype pACTII-PLZF results in a 2.4-fold increase of bgal activity with respect to the transfection of pGBT9-LAZ3 and empty pACTII. Each value represents the mean of at least ®ve independent transformation assays. ND=not done. Lower panel: Summary ®gure of the detected heteromerization interactions between LAZ3 and PLZF. The proven interactions are indicated by an arrow connecting the two domains. The question mark between the two POZ domains, means that the two isolated domains, though capable of ecient interaction, show no or only weak interaction when tested against the full length partner (see text)
LiAc method described by Gietz and Schiestl (1995) . The colorimetric b-galactosidase asays were performed as described in Rose et al., 1990) .
Northern blots, in vitro translation, Western blotting and GST pull down
Northern blot analysis were performed as previously described . The probes used were EcoRI fragments of the human LAZ3 cDNA (Kerckaert et al., 1993) and a full length PLZF cDNA (Licht et al., 1996) A b-actin probe was used as a loading control. The in vitro translations, Western blotting and GST pull down experiments were performed as described (Guidez et al., 1998) .
Immunofluoresence and imaging
Immuno¯uorescence experiments were performed as described (Koken et al., 1997) . Homemade (713 and 631, ) and commercial (C19 and N3, Santa Cruz Biotechnology, Inc.) polyclonal antibodies were used in a 1 : 100 to 1 : 200 dilution. The PLZF mouse monoclonal antibody and its use were previously described (Koken et al., 1997, and references therein) . PML monoclonal antibodies and Confocal microscopy were previously described (Koken et al., 1997 (Koken et al., , 1999 . CCD camera imaging was done on a Zeiss Axioscop Microscope (Carl Zeiss, Oberkochen, Germany) (Objectives 406NA 1.3 or 636NA 1.4 Plan NEOFLUAR) equipped with a tri-CCD camera (LH750 RC3, LHESA electronique, Cergy-pontoise, France). Acquision softwear: Photomat (Microvision Instrument, Evry, France), Treatment software: Matrox Inspector (Matrox Electronic System, Rungis, France).
